News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
624,179 Results
Type
Article (53731)
Company Profile (290)
Press Release (570158)
Multimedia
Podcasts (84)
Webinars (12)
Section
Business (170052)
Career Advice (2450)
Deals (31073)
Drug Delivery (121)
Drug Development (79482)
Employer Resources (153)
FDA (16530)
Job Trends (13438)
News (304866)
Policy (32231)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (12)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (4)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2699)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (84)
Alliances (44178)
ALS (97)
Alzheimer's disease (1490)
Antibody-drug conjugate (ADC) (133)
Approvals (16495)
Artificial intelligence (256)
Autoimmune disease (27)
Automation (14)
Bankruptcy (327)
Best Places to Work (10545)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (194)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (270)
Cancer (2169)
Cardiovascular disease (192)
Career advice (2048)
Career pathing (32)
CAR-T (154)
Cell therapy (435)
Cervical cancer (21)
Clinical research (64343)
Collaboration (804)
Compensation (516)
Complete response letters (30)
COVID-19 (2765)
CRISPR (44)
C-suite (232)
Cystic fibrosis (105)
Data (2054)
Decentralized trials (2)
Denatured (18)
Depression (49)
Diabetes (274)
Diagnostics (6190)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (42)
Drug discovery (124)
Drug pricing (120)
Drug shortages (30)
Duchenne muscular dystrophy (99)
Earnings (66067)
Editorial (43)
Employer branding (20)
Employer resources (138)
Events (94226)
Executive appointments (682)
FDA (17741)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (719)
Gene editing (114)
Generative AI (23)
Gene therapy (329)
GLP-1 (818)
Government (4400)
Grass and pollen (5)
Guidances (50)
Healthcare (17190)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (138)
Indications (26)
Infectious disease (2923)
Inflammatory bowel disease (149)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (95)
Interviews (452)
IPO (15316)
IRA (48)
Job creations (3366)
Job search strategy (1708)
Kidney cancer (10)
Labor market (30)
Layoffs (519)
Leadership (20)
Legal (7371)
Liver cancer (77)
Lung cancer (319)
Lymphoma (142)
Machine learning (5)
Management (52)
Manufacturing (293)
MASH (69)
Medical device (12232)
Medtech (12235)
Mergers & acquisitions (16276)
Metabolic disorders (735)
Multiple sclerosis (82)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (31)
Neuroscience (2057)
NextGen: Class of 2025 (5798)
Non-profit (4446)
Northern California (2504)
Now hiring (22)
Obesity (404)
Opinion (228)
Ovarian cancer (74)
Pain (85)
Pancreatic cancer (81)
Parkinson's disease (158)
Partnered (18)
Patents (234)
Patient recruitment (99)
Peanut (48)
People (50394)
Pharmaceutical (72)
Pharmacy benefit managers (21)
Phase I (19690)
Phase II (28197)
Phase III (21719)
Pipeline (1145)
Policy (157)
Postmarket research (2632)
Preclinical (8275)
Press Release (49)
Prostate cancer (101)
Psychedelics (37)
Radiopharmaceuticals (235)
Rare diseases (418)
Real estate (4908)
Recruiting (61)
Regulatory (22634)
Reports (33)
Research institute (2442)
Resumes & cover letters (407)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (76)
Series A (132)
Series B (84)
Service/supplier (10)
Sickle cell disease (58)
Southern California (2128)
Special edition (16)
Spinal muscular atrophy (162)
Sponsored (33)
Startups (3294)
State (1)
Stomach cancer (16)
Supply chain (71)
Tariffs (29)
The Weekly (65)
United States (21587)
Vaccines (776)
Venture capitalists (41)
Weight loss (291)
Women's health (32)
Worklife (19)
Date
Last 7 days (486)
Last 30 days (2208)
Last 365 days (32752)
2025 (9384)
2024 (34829)
2023 (39047)
2022 (49933)
2021 (53849)
2020 (51460)
2019 (41907)
2018 (31780)
2017 (31573)
2016 (30472)
2015 (34220)
2014 (27052)
2013 (22277)
2012 (23661)
2011 (23921)
2010 (22154)
Location
Africa (813)
Alabama (48)
Alaska (6)
Arizona (183)
Arkansas (11)
Asia (37161)
Australia (6482)
California (5686)
Canada (1742)
China (491)
Colorado (244)
Connecticut (279)
Delaware (132)
Europe (88118)
Florida (844)
Georgia (191)
Hawaii (1)
Idaho (54)
Illinois (485)
India (23)
Indiana (275)
Iowa (9)
Japan (150)
Kansas (94)
Kentucky (20)
Louisiana (10)
Maine (63)
Maryland (872)
Massachusetts (4355)
Michigan (189)
Minnesota (357)
Mississippi (1)
Missouri (75)
Montana (24)
Nebraska (23)
Nevada (55)
New Hampshire (56)
New Jersey (1648)
New Mexico (21)
New York (1630)
North Carolina (963)
North Dakota (7)
Northern California (2504)
Ohio (176)
Oklahoma (11)
Oregon (34)
Pennsylvania (1250)
Puerto Rico (9)
Rhode Island (23)
South America (1165)
South Carolina (20)
South Dakota (1)
Southern California (2128)
Tennessee (87)
Texas (826)
Utah (163)
Virginia (137)
Washington D.C. (61)
Washington State (528)
West Virginia (3)
Wisconsin (55)
624,179 Results for "parkinson s disease foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense
March 4, 2025
·
7 min read
Neurodegenerative disease
Inhibikase Scraps Parkinson’s Drug After Disappointing Mid-Stage Data
Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and abandoned assets in recent months.
January 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled
April 16, 2025
·
10 min read
Press Releases
Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer’s & Parkinson’s Diseases
March 28, 2025
·
4 min read
Press Releases
ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test for Parkinson’s Disease Developed
April 14, 2025
·
2 min read
Press Releases
Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.
April 3, 2025
·
7 min read
Neurodegenerative disease
7 Alzheimer’s and Parkinson’s Programs Discarded in 2024
This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are still chasing these multi-billion-dollar markets.
November 4, 2024
·
6 min read
·
Heather McKenzie
Press Releases
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
March 25, 2025
·
9 min read
Parkinson’s disease
Roche’s Prothena-Partnered Parkinson’s Drug Fails Mid-Stage Trial
The report comes just two days after Novartis announced its own Parkinson’s drug failure.
December 19, 2024
·
1 min read
·
Annalee Armstrong
Business
MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s Research
MilliporeSigma and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).
June 18, 2024
·
4 min read
1 of 62,418
Next
